Literature DB >> 9760579

Cross-presentation of self antigens to CD8+ T cells: the balance between tolerance and autoimmunity.

C Kurts1, W R Heath, F R Carbone, H Kosaka, J F Miller.   

Abstract

Upon encounter with foreign antigen, tissue-associated antigen-presenting cells (APCs) migrate to draining lymph nodes to prime specific T cells. Using the transgenic RIP-mOVA model, we recently demonstrated that self antigens derived from peripheral tissues are constitutively transported to draining lymph nodes, and can be presented in association with MHC class I molecules by a bone marrow-derived APC population. This form of class I-restricted presentation of exogenous antigen has been referred to as cross-presentation and can induce activation and proliferation of antigen-specific CD8+ T cells. In the absence of CD4+ T cell help, activation of CD8+ T cells is inefficient, and cross-presentation leads to peripheral deletion of autoreactive CD8+ T cells, acting as a mechanism to maintain self-tolerance. If CD4+ T cell help is available, CD8+ T cell responses to self antigens can be rendered immunogenic, leading to autoreactive responses. Whether autoimmunity results from such responses also depends on the tissue location of the antigen. In RIP-mOVA mice, which express the model antigen mOVA (a membrane-bound form of ovalbumin) in the pancreatic beta cells and kidney proximal tubules, OVA-specific CD8+ T cells, activated by cross-presentation, infiltrated the pancreas and caused B cell destruction. Interestingly, however, these cells did not infiltrate the kidney, suggesting that proximal tubular cells are to some extent protected from immune destruction. Analysis of the role of antigen concentration indicates that high doses were required for efficient cross-presentation, suggesting that this pathway is directed towards immune responses to high-dose antigens, such as may be present during viral infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9760579     DOI: 10.1002/9780470515525.ch13

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  7 in total

1.  Intravenous immunoglobulin modulates the expansion and cytotoxicity of CD8+ T cells.

Authors:  Patrick Trépanier; Dominique Chabot; Renée Bazin
Journal:  Immunology       Date:  2014-02       Impact factor: 7.397

2.  Loss of T cell CD98 H chain specifically ablates T cell clonal expansion and protects from autoimmunity.

Authors:  Joseph Cantor; Marina Slepak; Nil Ege; John T Chang; Mark H Ginsberg
Journal:  J Immunol       Date:  2011-06-13       Impact factor: 5.422

3.  CD4+ T cell help is dispensable for protective CD8+ T cell memory against mousepox virus following vaccinia virus immunization.

Authors:  Min Fang; Sanda Remakus; Felicia Roscoe; Xueying Ma; Luis J Sigal
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

4.  Optimal T-cell receptor affinity for inducing autoimmunity.

Authors:  Sabrina Koehli; Dieter Naeher; Virginie Galati-Fournier; Dietmar Zehn; Ed Palmer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-19       Impact factor: 11.205

5.  Memory CD8+ T cells are gatekeepers of the lymph node draining the site of viral infection.

Authors:  Ren-Huan Xu; Min Fang; Andres Klein-Szanto; Luis J Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

Review 6.  T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes.

Authors:  Adam L Burrack; Tijana Martinov; Brian T Fife
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-05       Impact factor: 5.555

Review 7.  Radiation-induced inflammation and autoimmune diseases.

Authors:  Rasoul Yahyapour; Peyman Amini; Saeed Rezapour; Mohsen Cheki; Abolhasan Rezaeyan; Bagher Farhood; Dheyauldeen Shabeeb; Ahmed Eleojo Musa; Hengameh Fallah; Masoud Najafi
Journal:  Mil Med Res       Date:  2018-03-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.